vimarsana.com

Page 5 - Morningside Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson s Disease

/PRNewswire/ MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset in development for the.

United statesBrian harrisTerry ellisDepartment of physical therapyAmerican physical therapy association combined sections meetingSargent collegeBoston universityBoston university college of health rehabilitation sciencesAssociate professorPhysical therapyBoston university collegeRehabilitation sciencesBreakthrough deviceMorningside venturesHealth care amp hospitalsMedical pharmaceuticals

MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke

/PRNewswire/ MedRhythms announced today that the company s pivotal trial for MR-001, a novel digital intervention in development to treat gait deficits in.

United statesPrnewswire medrhythmsBrian harrisShirley ryan abilitylabKessler foundationUniversity of north carolina at chapel hillBoston university neuromotor recovery laboratoryMount sinai health systemAtrium healthSpaulding rehabilitation hospitalNorth carolinaBreakthrough deviceMorningside ventures

NewAmsterdam Announces Appointment of David Topper as Chief

NAARDEN, the Netherlands and MIAMI, Dec. 19, 2022 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq:NAMS or “NewAmsterdam” or the “Company”),.

United statesNoord hollandCarmen lopezLouise kooijMichael davidsonHannah deresiewiczJohn kasteleinMorgan stanleyTermgrid incEquity commitment committeeNeither the companyStanford graduate school of businessPortfolio committeeNewamsterdam pharma companynv nasdaqCircleup network incSenior advisor to frazier life sciences

MedRhythms Recognized for Advancements in Prescription Digital Therapeutics from CB Insights, Reuters Events Pharma and Fast Company

/PRNewswire/ CB Insights today announced that, for the second year in a row, MedRhythms has been named to its annual Digital Health 150, a list that.

New yorkUnited statesUnited kingdomNorth lanarkshireBrian harrisBrian leeBrendan vaughanLauren steidlMusic groupDigital healthMansueto venturesFast companyDrug administrationMost valuable digital therapyEvents pharma awardsBig things

NewAmsterdam Pharma Announces Initiation of Phase 2 Dose-Finding Study Evaluating Obicetrapib in Japanese Patients

NewAmsterdam Pharma, a clinical-stage company focused on the research and development of transformative oral therapies for metabolic diseases, today announced that it has initiated a Phase 2 dose-finding

Two union squareUnited statesMenlo parkCayman islandsNewamsterdam pharmaKostenloser wertpapierhandelCarmen lopezMichael davidsonHannah deresiewiczJohn kasteleinMenarini groupNewamsterdam pharma holdingCompany or newamsterdam pharmaUnion stFrazier lifesciences acquisition corporationUnion square

vimarsana © 2020. All Rights Reserved.